A ()follow-up period means that serious adverse reactions may not be identified because they do not develop immediately. A ()inclusion/exclusion criteria means the population used in the study is likely healthier, excludes children, elderly and pregnant or breast feeding women, uses no/limited concomitant medications, and has a less complicated medical history than the general population that will actually end up using the medication.